Aerogen & Lyomark Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial
Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Lyomark Pharma, an established provider of high-quality medicines for the hospital…
Read More...
Read More...
